Regenerative tissue grafts and methods of making same
US10507187B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Feb 12, 2014 |
| Grant date | Dec 17, 2019 |
| Priority date | — |
| Expiry date | Feb 12, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A graft containing a scaffold that includes a matrix in which are positioned mesenchymal progenitor cells (MPCs) has the capacity to substantially improve wound healing, including wounds resulting from injury to nerve, bone and vascular tissue. MPCs can be harvested from debrided muscle tissue following orthopaedic trauma. The traumatized muscle-derived progenitor cells are a readily available autologous cell source that can be utilized to effect or improve wound healing in a variety of therapeutic settings and vehicles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.